glp-1 and glp-2 The Possible Involvement of Glucagon-like Peptide-2 in the Regulation of Food Intake through the Gut–Brain Axis Positive impact of GIP, GLP-1

Follow-Up Visits and Outcomes Three-Month Check Weight: Down 3 kg (BMI 34 kg/m) HbA1c: Decreased to 7.8% from 8.6% Blood Pressure: Controlled at 128/80 mmHg Side Effects: Mild nausea during the first few weeks, which subsided with slow dose titration Six-Month Check Weight: Down a total of 6 kg (BMI 33 kg/m) HbA1c: Further improvement to 7.3% Cardiometabolic Indicators: Mild improvement in LDL cholesterol (from 110 mg/dL to 98 mg/dL)

Maybe you need more tests

Missing or incomplete notes are one of the fastest ways to lose revenue

Side Effects Both medications come with potential side effects: Semaglutide: Nausea and vomiting Diarrhea or constipation Low blood sugar (hypoglycemia) Topiramate: Dizziness and fatigue Numbness or tingling in the extremities Mood changes or difficulty concentrating While side effects may vary from person to person, they often diminish over time as the body adjusts to the medication